{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:11:44Z","timestamp":1791472304452,"version":"4.3.4"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1097\/iop.0b013e31816386e1","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T03:01:25Z","timestamp":1205377285000},"page":"113-116","source":"Crossref","is-referenced-by-count":8,"title":["Pain Relief in Patients Receiving Periocular Botulinum Toxin A"],"prefix":"10.1097","volume":"24","author":[{"given":"Andrew R.","family":"Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00055735-200310000-00003","article-title":"Chemodenervation for facial dystonias and wrinkles.","volume":"14","author":"Harrison","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"key":"R2-7-20210129","first-page":"924","article-title":"Pharmacological weakening of extraocular muscles.","volume":"12","author":"Scott","year":"1973","journal-title":"Invest Ophthalmol"},{"key":"R3-7-20210129","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.","volume":"87","author":"Scott","year":"1980","journal-title":"Ophthalmology"},{"key":"R4-7-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archopht.1985.01050030043017","article-title":"Botulinum A toxin injection as a treatment for blepharospasm.","volume":"103","author":"Scott","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"R5-7-20210129","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0002-9394(14)77954-1","article-title":"The use of botulinum toxin in blepharospasm.","volume":"99","author":"Shorr","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"R6-7-20210129","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0161-6420(88)32977-5","article-title":"Long-term results and complications of botulinum toxin in the treatment of blepharospasm.","volume":"95","author":"Dutton","year":"1988","journal-title":"Ophthalmology"},{"key":"R7-7-20210129","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0002-9394(85)90797-4","article-title":"Sequelae of botulinum toxin injection.","volume":"100","author":"Lingua","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"R8-7-20210129","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archopht.1985.01050090057031","article-title":"Hemifacial spasm treated with botulinum a toxin injection.","volume":"103","author":"Savino","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"R9-7-20210129","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1212\/WNL.35.10.1499","article-title":"Blepharospasm, Meige syndrome, and hemifacial spasm: Treatment with botulinum toxin","volume":"35","author":"Mauriello","year":"1985","journal-title":"Neurology"},{"key":"R10-7-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0161-6420(86)33785-0","article-title":"The use of botulinum toxin in the medical management of benign essential blepharospasm.","volume":"93","author":"Perman","year":"1986","journal-title":"Ophthalmology"},{"key":"R11-7-20210129","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0161-6420(86)33641-8","article-title":"Treatment of facial spasm with botulinum toxin.","volume":"93","author":"Frueh","year":"1986","journal-title":"Ophthalmology"},{"key":"R12-7-20210129","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0161-6420(87)33338-X","article-title":"Effectiveness of botulinum toxin therapy for essential blepharospasm.","volume":"94","author":"Engstrom","year":"1987","journal-title":"Ophthalmology"},{"key":"R13-7-20210129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.870020402","article-title":"Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.","volume":"2","author":"Brin","year":"1987","journal-title":"Movement Disorders"},{"key":"R14-7-20210129","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","article-title":"Botulinum A toxin for cranial-cervical dystonia: A double-blind, placebo-controlled study.","volume":"37","author":"Jankovic","year":"1987","journal-title":"Neurology"},{"key":"R15-7-20210129","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/jnnp.53.8.633","article-title":"Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.","volume":"53","author":"Jankovic","year":"1990","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R16-7-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0039-6257(97)81995-9","article-title":"Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.","volume":"41","author":"Dutton","year":"1996","journal-title":"Surv Ophthalmol"},{"key":"R17-7-20210129","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1185\/030079904125003962","article-title":"Safety of botulinum toxin type A: a systematic review and meta-analysis.","volume":"20","author":"Naumann","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"R18-7-20210129","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00042728-200504000-00007","article-title":"Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females.","volume":"31","author":"Carruthers","year":"2005","journal-title":"Dermatol Surg"},{"key":"R19-7-20210129","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1526-4610.1999.3909662.x","article-title":"Improvement of tension-type headaches when treating wrinkles with botulinum toxin A injections.","volume":"39","author":"Carruthers","year":"1999","journal-title":"Headache J Head Face Pain"},{"key":"R20-7-20210129","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1526-4610.1998.3805366.x","article-title":"Headache and facial pain responsive to botulinum toxin: an unusual presentation of blepharospasm.","volume":"38","author":"Johnstone","year":"1998","journal-title":"Headache"},{"key":"R21-7-20210129","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1468-2982.1998.1810709.x","article-title":"Facial pain in a case of cranial dystonia: a case report.","volume":"18","author":"Kunig","year":"1998","journal-title":"Cephalalgia"},{"key":"R22-7-20210129","first-page":"321","article-title":"Dystonia and headaches: clinical features and response to botulinum toxin therapy.","volume":"94","author":"Galvez-Jimenez","year":"2004","journal-title":"Adv Neurol"},{"key":"R23-7-20210129","first-page":"388","article-title":"Resolution of chronic tension headache after botulinum toxin treatment of idiopathic blepharospasm.","volume":"10","author":"Krack","year":"1995","journal-title":"Movement Disorders"},{"key":"R24-7-20210129","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00002341-199911000-00003","article-title":"A novel mechanism for benign essential blepharospasm.","volume":"15","author":"McCann","year":"1999","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R25-7-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3959(01)00292-5","article-title":"Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes.","volume":"91","author":"Gobel","year":"2001","journal-title":"Pain"},{"key":"R26-7-20210129","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1097\/00002508-200211001-00005","article-title":"Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction.","volume":"18","author":"Lew","year":"2002","journal-title":"Clin J Pain"},{"key":"R27-7-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2005.04.017","article-title":"Expanding use of botulinum toxin.","volume":"235","author":"Bhidayasiri","year":"2005","journal-title":"J Neurol Sci"},{"key":"R28-7-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clindermatol.2003.11.013","article-title":"Botox: beyond wrinkles.","volume":"22","author":"Carruthers","year":"2004","journal-title":"Clin Dermatol"},{"key":"R29-7-20210129","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1526-4610.1994.hed3408458.x","article-title":"Tension headache: botulinum toxin paralysis of temporal muscles.","volume":"34","author":"Zwart","year":"1994","journal-title":"Headache"},{"key":"R30-7-20210129","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1526-4610.2000.00044.x","article-title":"Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study.","volume":"40","author":"Rollnik","year":"200","journal-title":"Headache"},{"key":"R31-7-20210129","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1526-4610.2001.041007658.x","article-title":"Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial.","volume":"41","author":"Schmitt","year":"2001","journal-title":"Headache"},{"key":"R32-7-20210129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1468-2982.2004.00738.x","article-title":"Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial.","volume":"24","author":"Padberg","year":"2004","journal-title":"Chephalalgia"},{"key":"R33-7-20210129","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pain.2004.01.016","article-title":"Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.","volume":"109","author":"Schulte-Mattler","year":"2004","journal-title":"Pain"},{"key":"R34-7-20210129","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1526-4610.1998.3806468.x","article-title":"Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension.","volume":"38","author":"Wheeler","year":"1998","journal-title":"Headache"},{"key":"R35-7-20210129","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1067\/mhn.2000.110960","article-title":"Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open-label study.","volume":"123","author":"Binder","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R36-7-20210129","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1526-4610.2003.03163.x","article-title":"Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.","volume":"43","author":"Blumenfeld","year":"2003","journal-title":"Headache"},{"issue":"suppl 1","key":"R37-7-20210129","first-page":"112","article-title":"Botulinum toxin in tension-type headache.","volume":"251","author":"Relja","year":"2004","journal-title":"J Neurol"},{"key":"R38-7-20210129","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/00023210-200317060-00001","article-title":"Preventative treatment for migraine and tension-type headaches do drugs having effects on muscle spasm and tone have a role?","volume":"17","author":"Freitag","year":"2003","journal-title":"CNS Drugs"},{"key":"R39-7-20210129","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/mds.870090221","article-title":"Effectiveness of botulinum toxin type A against painful limb myoclonus of spinal cord origin.","volume":"9","author":"Polo","year":"1994","journal-title":"Movement Disorders"},{"key":"R40-7-20210129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3959(94)90048-5","article-title":"Botulinum toxin in the treatment of myofacial pain syndrome.","volume":"59","author":"Cheshire","year":"1994","journal-title":"Pain"},{"key":"R41-7-20210129","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/00016489309135834","article-title":"Botulinum A toxin effects on rat jaw muscle spindles.","volume":"113","author":"Filippi","year":"1993","journal-title":"Acta Otolaryngologica"},{"key":"R42-7-20210129","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8","article-title":"Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection.","volume":"19","author":"Rosales","year":"1996","journal-title":"Muscle Nerve"},{"key":"R43-7-20210129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00500893","article-title":"The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex.","volume":"298","author":"Wiegand","year":"1977","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R44-7-20210129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00498587","article-title":"125I-labeled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection.","volume":"292","author":"Wiegand","year":"1976","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R45-7-20210129","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/exnr.1999.7268","article-title":"Enkephalin and aFGF are differentially regulated in rat spinal motoneurons after chemodenervation with botulinum toxin.","volume":"161","author":"Humm","year":"2000","journal-title":"Exp Neurol"},{"key":"R46-7-20210129","doi-asserted-by":"crossref","first-page":"542S","DOI":"10.1042\/bst025542s","article-title":"Capsaicin stimulates release of substance P from dorsal root ganglion neurons via two distinct mechanisms.","volume":"25","author":"Purkiss","year":"1997","journal-title":"Biochem Soc Trans"},{"key":"R47-7-20210129","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0021-5155(99)00197-5","article-title":"Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles.","volume":"44","author":"Ishikawa","year":"2000","journal-title":"Japan J Ophthalmol"},{"key":"R48-7-20210129","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1523\/JNEUROSCI.15-01-00520.1995","article-title":"Calcitonin gene-related peptide: possible role in formation and maintenance of neuromuscular junctions.","volume":"15","author":"Sala","year":"1995","journal-title":"J Neurosci"},{"key":"R49-7-20210129","first-page":"414","article-title":"Botulinum toxin type a (BTX-a) reduces inflammatory pain in the rat formalin model (abstract).","volume":"20","author":"Cui","year":"2000","journal-title":"Cephalalgia"},{"key":"R50-7-20210129","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1468-2982.2006.01114.x","article-title":"Botulinum toxin type A in the proylactic treatment of chronic tension-type headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study.","volume":"7","author":"Silberstein","year":"2006","journal-title":"Cephalgia"},{"key":"R51-7-20210129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1526-4610.2005.05066.x","article-title":"Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.","volume":"45","author":"Mathew","year":"2005","journal-title":"Headache"},{"key":"R52-7-20210129","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1524-4725.1998.tb04257.x","article-title":"Botulinum A neurotoxin for axillary hyperhydrosis.","volume":"24","author":"Glogau","year":"1998","journal-title":"Dermatol Surg"}],"container-title":["Ophthalmic Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IOP.0b013e31816386e1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:53:14Z","timestamp":1786035194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002341-200803000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/iop.0b013e31816386e1","relation":{},"ISSN":["0740-9303"],"issn-type":[{"value":"0740-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}